Literature DB >> 20573594

Brown spider venom toxins interact with cell surface and are endocytosed by rabbit endothelial cells.

Jenifer Nowatzki1, Reginaldo Vieira de Sene, Katia Sabrina Paludo, Silvio Sanches Veiga, Constance Oliver, Maria Célia Jamur, Helena Bonciani Nader, Edvaldo S Trindade, Célia Regina C Franco.   

Abstract

Bites from the Loxosceles genus (brown spiders) cause severe clinical symptoms, including dermonecrotic injury, hemorrhage, hemolysis, platelet aggregation and renal failure. Histological findings of dermonecrotic lesions in animals exposed to Loxosceles intermedia venom show numerous vascular alterations. Study of the hemorrhagic consequences of the venom in endothelial cells has demonstrated that the degeneration of blood vessels results not only from degradation of the extracellular matrix molecule or massive leukocyte infiltration, but also from a direct and primary activity of the venom on endothelial cells. Exposure of an endothelial cell line in vitro to L. intermedia venom induce morphological alterations, such as cell retraction and disadhesion to the extracellular matrix. The aim of the present study was to investigate the interaction between the venom toxins and the endothelial cell surface and their possible internalization, in order to illuminate the information about the deleterious effect triggered by venom. After treating endothelial cells with venom toxins, we observed that the venom interacts with cell surface. Venom treatment also can cause a reduction of cell surface glycoconjugates. When cells were permeabilized, it was possible to verify that some venom toxins were internalized by the endothelial cells. The venom internalization involves endocytic vesicles and the venom was detected in the lysosomes. However, no damage to lysosomal integrity was observed, suggesting that the cytotoxic effect evoked by L. intermedia venom on endothelial cells is not mediated by venom internalization. Copyright 2010 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20573594     DOI: 10.1016/j.toxicon.2010.03.027

Source DB:  PubMed          Journal:  Toxicon        ISSN: 0041-0101            Impact factor:   3.033


  6 in total

1.  Whole venom of Loxosceles similis activates caspases-3, -6, -7, and -9 in human primary skin fibroblasts.

Authors:  Arthur Estanislau Dantas; Carolina Campolina Rebello Horta; Thais M M Martins; Anderson Oliveira do Carmo; Bárbara Bruna Ribeiro de Oliveira Mendes; Alfredo M Goes; Evanguedes Kalapothakis; Dawidson A Gomes
Journal:  Toxicon       Date:  2014-04-12       Impact factor: 3.033

Review 2.  Highlights in the knowledge of brown spider toxins.

Authors:  Daniele Chaves-Moreira; Andrea Senff-Ribeiro; Ana Carolina Martins Wille; Luiza Helena Gremski; Olga Meiri Chaim; Silvio Sanches Veiga
Journal:  J Venom Anim Toxins Incl Trop Dis       Date:  2017-02-08

3.  Effects of copaiba oil on dermonecrosis induced by Loxosceles intermedia venom.

Authors:  Mara Fernandes Ribeiro; Felipe Leite de Oliveira; Aline Moreira Souza; Thelma de Barros Machado; Priscilla Farinhas Cardoso; Andrea Patti; Angélica Silveira Nascimento; Cláudio Maurício Vieira de Souza; Sabrina Calil Elias
Journal:  J Venom Anim Toxins Incl Trop Dis       Date:  2019-04-25

4.  Acanthocytosis and brain damage in area postrema and choroid plexus: Description of novel signs of Loxosceles apachea envenomation in rats.

Authors:  Luis Fernando Plenge-Tellechea; Ángel Daniel Hernández-Ramos; Juan Manuel Muñoz; Guillermo Barraza-Garza; Edna Rico-Escobar; David Meléndez-Martínez
Journal:  PLoS One       Date:  2019-02-07       Impact factor: 3.240

Review 5.  Immunological Responses to Envenomation.

Authors:  Rachael Y M Ryan; Jamie Seymour; Alex Loukas; J Alejandro Lopez; Maria P Ikonomopoulou; John J Miles
Journal:  Front Immunol       Date:  2021-05-10       Impact factor: 7.561

6.  A new theraphosid spider toxin causes early insect cell death by necrosis when expressed in vitro during recombinant baculovirus infection.

Authors:  Daniel Mendes Pereira Ardisson-Araújo; Fabrício Da Silva Morgado; Elisabeth Ferroni Schwartz; Gerardo Corzo; Bergmann Morais Ribeiro
Journal:  PLoS One       Date:  2013-12-13       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.